Clinical trial
Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For…
NCT00143169 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143169 |
|---|---|
| Title | Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain |
| Official title | A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Of Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain Following Orthopedic Or Gynecological Surgery |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Postoperative |
| Intervention type | Drug |
| Interventions | Parecoxib and placebo |
| Enrollment | 220 |
| Start date | Sep 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Apr 15, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: